1. Novel 11-norbetaenone isolated from an entomopathogenic fungus Lecanicillium antillanum
- Author
-
Chi-Ying Li, Yu-Ming Hsu, Hao-Chun Hu, Yi-Hung Liu, Yu-Ming Chung, Shih-Wei Wang, Sung-Pin Tseng, Yang Chang Wu, Shu-Rong Chen, Tsong-Long Hwang, I-Wen Lo, Yuan-Bin Cheng, and Fang Rong Chang
- Subjects
Models, Molecular ,0301 basic medicine ,Magnetic Resonance Spectroscopy ,Stereochemistry ,Chemical structure ,Hypocreales ,Clinical Biochemistry ,Lecanicillium antillanum ,Pharmaceutical Science ,Angiogenesis Inhibitors ,Secondary metabolite ,Crystallography, X-Ray ,01 natural sciences ,Biochemistry ,Microbiology ,03 medical and health sciences ,Drug Discovery ,medicine ,Humans ,Molecular Biology ,Endothelial Progenitor Cells ,Tube formation ,biology ,010405 organic chemistry ,Chemistry ,Organic Chemistry ,Nuclear magnetic resonance spectroscopy ,biology.organism_classification ,0104 chemical sciences ,030104 developmental biology ,Entomopathogenic fungus ,Molecular Medicine ,Diterpenes ,11-norbetaenone ,medicine.drug - Abstract
A novel nor-betaenone compound, 11-norbetaenone (1), was isolated from the culture broth of an entomopathogenic fungus Lecanicillium antillanum. The structure was determined on the basis of 1D and 2D NMR spectroscopic data. The absolute stereochemistry of 1 was further confirmed by X-ray single crystallography analysis. It is the first secondary metabolite reported from the species Lecanicillium antillanum. And it is also the first time that a betaenone-type compound was isolated from the genus Lecanicillium. Furthermore, 11-norbetaenone (1) displayed significant anti-angiogenic effect by suppressing tube formation.
- Published
- 2017